Article info

Download PDFPDF
The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status
  1. Correspondence to:
 Dr D Sahni
 Skin Tumour Unit, St John’s Institute of Dermatology, St Thomas’s Hospital, Lambeth Palace Road, London SE1 7EH, UK; debjani_sahnihotmail.com
View Full Text

Citation

Sahni D, Robson A, Orchard G, et al
The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status

Publication history

  • Accepted September 3, 2004
  • First published June 23, 2005.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.